P A Pavco

1.6k total citations
25 papers, 1.3k citations indexed

About

P A Pavco is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Clinical Biochemistry. According to data from OpenAlex, P A Pavco has authored 25 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 8 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Clinical Biochemistry. Recurrent topics in P A Pavco's work include RNA and protein synthesis mechanisms (9 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Mitochondrial Function and Pathology (4 papers). P A Pavco is often cited by papers focused on RNA and protein synthesis mechanisms (9 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Mitochondrial Function and Pathology (4 papers). P A Pavco collaborates with scholars based in United States and Japan. P A Pavco's co-authors include Deborah A. Steege, Glenn C. Van Tuyle, Karyn Bouhana, Francine E. Wincott, Adalberto M. Gallegos, James A. McSwiggen, Lawrence M. Blatt, Bharat M. Chowrira, Karin S. Blanchard and Lori Andrews and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

P A Pavco

25 papers receiving 1.2k citations

Peers

P A Pavco

GENET

RNMI

HEPAT

Gail Urlaub United States

Stephan Beck United Kingdom

P A Sharp United States

Alexandre Akoulitchev United Kingdom

Robert R. Flandermeyer United States

Andrea Leitch United Kingdom

C. S. Gilbert United Kingdom

H D Royer Germany

Paola Delmastro Italy

Andreas Klein Germany

Gail Urlaub United States

P A Pavco

1.5k ×1.3

426 ×2.0

GENET

88 ×0.5

109 ×0.8

RNMI

10 ×0.1

HEPAT

Citations per year, relative to P A Pavco P A Pavco (= 1×) peers Gail Urlaub

Countries citing papers authored by P A Pavco

Since Specialization

Citations

This map shows the geographic impact of P A Pavco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P A Pavco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P A Pavco more than expected).

Fields of papers citing papers by P A Pavco

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P A Pavco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P A Pavco. The network helps show where P A Pavco may publish in the future.

Co-authorship network of co-authors of P A Pavco

This figure shows the co-authorship network connecting the top 25 collaborators of P A Pavco. A scholar is included among the top collaborators of P A Pavco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P A Pavco. P A Pavco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cardia, James, et al.. (2015). Diphencyprone Treatment of Alopecia Areata: Postulated Mechanism of Action and Prospects for Therapeutic Synergy with RNA Interference. Journal of Investigative Dermatology Symposium Proceedings. 17(2). 16–18. 3 indexed citations

Kornbrust, Doug, Joy Cavagnaro, Arthur A. Levin, et al.. (2013). Oligo Safety Working Group Exaggerated Pharmacology Subcommittee Consensus Document. Nucleic Acid Therapeutics. 23(1). 21–28. 32 indexed citations

Byrne, Michael, Radouil Tzekov, Yi Wang, et al.. (2013). Novel Hydrophobically Modified Asymmetric RNAi Compounds (sd-rxRNA) Demonstrate Robust Efficacy in the Eye. Journal of Ocular Pharmacology and Therapeutics. 29(10). 855–864. 61 indexed citations

Byrne, Michael, et al.. (2012). Novel Anti-CTGF RNAi Therapy for Treatment of Proliferative Vitreoretinopathy (PVR) and other Ocular Disorders. 53(14). 6262–6262. 1 indexed citations

Salomon, William E., et al.. (2010). Modified dsRNAs that are not processed by Dicer maintain potency and are incorporated into the RISC. Nucleic Acids Research. 38(11). 3771–3779. 23 indexed citations

Shen, Jikui, Hideo Akiyama, Yoshitsugu Saishin, et al.. (2005). Suppression of ocular neovascularization with siRNA targeting VEGF receptor 1. Gene Therapy. 13(3). 225–234. 236 indexed citations

Morrissey, Dylan, David A. Johnson, James A. McSwiggen, et al.. (2002). Characterization of nuclease‐resistant ribozymes directed against hepatitis B virus RNA*. Journal of Viral Hepatitis. 9(6). 411–418. 19 indexed citations

Macejak, Dennis G., Kristi Jensen, P A Pavco, et al.. (2001). Enhanced antiviral effect in cell culture of type 1 interferon and ribozymes targeting HCV RNA. Journal of Viral Hepatitis. 8(6). 400–405. 24 indexed citations

Bouhana, Karyn, et al.. (2000). Ribozyme Pharmacokinetic Screening For Predicting Pharmacodynamic Dosing Regimens. Current Issues in Molecular Biology. 2(4). 113–8. 6 indexed citations

10.

Macejak, Dennis G., Kristi Jensen, Sharon F. Jamison, et al.. (2000). Inhibition of hepatitis C virus (HCV)-RNA-dependent translation and replication of a chimeric HCV poliovirus using synthetic stabilized ribozymes. Hepatology. 31(3). 769–776. 93 indexed citations

11.

Lee, Patrice A., Lawrence M. Blatt, Karin S. Blanchard, et al.. (2000). Pharmacokinetics and Tissue Distribution of a Ribozyme Directed Against Hepatitis C Virus RNA Following Subcutaneous or Intravenous Administration in Mice. Hepatology. 32(3). 640–646. 38 indexed citations

12.

Pavco, P A, Karyn Bouhana, Adalberto M. Gallegos, et al.. (2000). Antitumor and antimetastatic activity of ribozymes targeting the messenger RNA of vascular endothelial growth factor receptors.. PubMed. 6(5). 2094–103. 129 indexed citations

13.

Jarvis, Thale C., Karyn Bouhana, Mark E. Lesch, et al.. (2000). Ribozymes as Tools for Therapeutic Target Validation in Arthritis. The Journal of Immunology. 165(1). 493–498. 14 indexed citations

14.

Sandberg, Jennifer A., Karyn Bouhana, Adalberto M. Gallegos, et al.. (1999). Pharmacokinetics of an Antiangiogenic Ribozyme (ANGIOZYME™) in the Mouse. Antisense and Nucleic Acid Drug Development. 9(3). 271–277. 40 indexed citations

15.

Parry, Tom J., Cynthia D. Cushman, Adalberto M. Gallegos, et al.. (1999). Bioactivity of anti-angiogenic ribozymes targeting Flt-1 and KDR mRNA. Nucleic Acids Research. 27(13). 2569–2577. 70 indexed citations

16.

Chowrira, Bharat M., P A Pavco, & James A. McSwiggen. (1994). In vitro and in vivo comparison of hammerhead, hairpin, and hepatitis delta virus self-processing ribozyme cassettes.. Journal of Biological Chemistry. 269(41). 25856–25864. 55 indexed citations

17.

Pavco, P A & Deborah A. Steege. (1991). Characterization of elongating T7 and SP6 RNA polymerases and their response to a roadblock generated by a site-specific DNA binding protein. Nucleic Acids Research. 19(17). 4639–4646. 42 indexed citations

18.

Hoke, Glenn D., P A Pavco, Brian J. Ledwith, & Glenn C. Van Tuyle. (1990). Structural and functional studies of the rat mitochondrial single strand DNA binding protein P16. Archives of Biochemistry and Biophysics. 282(1). 116–124. 46 indexed citations

19.

Pavco, P A & Glenn C. Van Tuyle. (1985). Purification and general properties of the DNA-binding protein (P16) from rat liver mitochondria.. The Journal of Cell Biology. 100(1). 258–264. 40 indexed citations

20.

Tuyle, Glenn C. Van & P A Pavco. (1981). Characterization of a rat liver mitochondrial DNA-protein complex. Replicative intermediates are protected against branch migrational loss.. Journal of Biological Chemistry. 256(24). 12772–12779. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact